SGLT2 inhibitors may protect type 2 diabetes patients from gout: JAMA Medha Baranwal22 Nov 2021 10:45 AM ISTTaiwan: A recent study in JAMA Network Open has shown that the use of SGLT2 inhibitors in type 2 diabetes (T2D) patients are associated with an 11%...
SGLT 2 inhibitors provide kidney, cardiovascular benefits for diabetes patients Dr. Nandita Mohan13 Nov 2021 2:59 PM ISTIn addition to lowering blood sugar levels, diabetes drugs called Sodium-glucose cotransporter 2 (SGLT2) inhibitors can provide kidney- and...
Medical Bulletin 11/November/2021 Dr. Nandita Mohan11 Nov 2021 5:29 PM ISTHere are Top Medical Stories of the dayHEPA air cleaners benefit COPD patients An environmental intervention study by Nadia N Hansel and team has...
SGLT2 inhibitors may protect kidney and heart in adults with type 1 diabetes: Study Hina Zahid9 Nov 2021 10:15 AM ISTSan Diego - In addition to lowering blood sugar levels, diabetes drugs called Sodium-glucose cotransporter 2 (SGLT2) inhibitors can provide kidney-...
Type 2 diabetes: SGLT2 inhibitors not tied to fracture risk in older adults, finds study Medha Baranwal30 Oct 2021 10:00 AM ISTBoston, MA: A recent study in the JAMA Network Open has shown that the initiation of SGLT2 inhibitors does not appear to increase the risk of fracture...
Empagliflozin reduces hospitalization and mortality in HF with preserved EF, NEJM. dr. Abhimanyu Uppal16 Oct 2021 10:00 AM ISTAlthough pharmacologic therapies that improve clinical outcomes have been identified for use in patients with heart failure and a reduced ejection...
SGLT2i tied to lower mortality and better outcomes than DPP4i, finds Study Medha Baranwal7 Sept 2021 10:15 AM ISTItaly: Initiation of SGLT2 inhibitors under routine care versus initiation of DPP4 inhibitors leads to better cardiorenal outcomes and lower mortality...
Cardiac, metabolic and renal effects of SGLT2 inhibitors: Position Statement Medha Baranwal3 Aug 2021 11:15 AM ISTDelhi: The European Society of Cardiology has released position statements on the cardiac, metabolic, and renal effects of sodium-glucose...
SGLT2 inhibitor dapagliflozin safe and effective in patients with advanced kidney disease: Study Hina Zahid21 July 2021 6:15 PM ISTThe effects of dapagliflozin in patients with stage 4 CKD are similar to effects in patients with mild to moderate CKD. USA: The benefits of...
SGLT2 inhibitors improve survival over DPP4i in patients with cirrhosis and diabetes: Study Medha Baranwal20 July 2021 11:45 AM ISTPatients with cirrhosis needing additional pharmacotherapy for diabetes beyond metformin experience increased survival with SGLT2i in relation to...
Diabetes: Study suggests SGLT2 inhibitors role in primary prevention of diabetic kidney disease Medha Baranwal19 July 2021 10:48 AM ISTDelhi: Dapagliflozin, an SGLT2 inhibitor, may be used for the primary prevention of diabetic kidney disease, suggests recent results from DECLARE-TIMI...
Liraglutide addition to SGLT2 inhibitors intensifies type 2 diabetes treatment: Study Medha Baranwal17 July 2021 12:45 PM ISTDelhi: Liraglutide (1.8 mg) seems to be an effective way to intensify the treatment of type 2 diabetes irrespective of BMI, HbA1c, insulin resistance,...
